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It is well established that L-type calcium channels (LTCCs) are expressed in astroglia. However, their
functional role is still speculative, especially under pathologic conditions. We recently showed that the a1
subunit-like immunoreactivity of the CaV1.2 channel is strongly expressed in reactive astrocytes around
beta-amyloid plaques in 11-month-old Alzheimer transgenic (tg) mice with the amyloid precursor protein
London and Swedish mutations. The aim of the present study was to examine the cellular expression of all
LTCC subunits around beta-amyloid plaques by in situ hybridization using 35S-labeled oligonucleotides. Our
data show that messenger RNAs (mRNAs) of the LTCC CaV1.2 a1 subunit as well as all auxiliary b and a2d
subunits, except a2d-4, were expressed in the hippocampus of age-matched wild-type mice. It was un-
expected to see, that cells directly located in the plaque core in the cortex expressed mRNAs for CaV1.2 a1,
b2, b4, and a2d-1, whereas no expressionwas detected in the halo. Furthermore, cells in the plaque core also
expressed preprotachykinin-A mRNA, the precursor for substance P. By means of confocal microscopy, we
demonstrated that collagen-IV-stained brain vessels in the cortex were associated with the plaque core and
were immunoreactive for substance P. In cortical organotypic brain slices of adult Alzheimer mice, we
could demonstrate that LTCC blockers increased angiogenesis, which was further potentiated by substance
P. In conclusion, our data show that brain vessels associated with beta-amyloid plaques express substance P
and an LTCC and may play a role in angiogenesis.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Progressive impairment in memory and cognition is a key clin-
ical feature of Alzheimer’s disease (AD). The disorder is morpho-
logically characterized by the extracellular deposition of b-amyloid
(Ab), intraneuronal tau pathology, synaptic loss, neuronal cell
death, Ab angiopathy, and inﬂammatory processes. Besides thesetry and Psychotherapy, Uni-
ical University of Innsbruck,
512 504 23712; fax: þ43 512
umpel).
Inc. This is an open access articlehallmarks of AD, altered Ca2þ regulation is likely to play an
important role in AD pathology (Thibault et al., 2007). It has been
suggested that increased activity of L-type calcium channels
(LTCCs) drives many of the markers of pathology in aging and AD
brains. LTCCs consist of a pore-forming a1 subunit (CaV1.1, CaV1.2,
CaV1.3, or CaV1.4) and accessory a2d and b subunits (Arikkath and
Campbell, 2003; Catterall, 2000; Striessnig et al., 2006). Although
a1 subunits form the proper channel pore and contain the voltage
sensor, they also exhibit pharmacologic properties. On the other
hand, the accessory subunits regulate membrane expression
and gating properties of the Ca2þ channels (Obermair and Flucher,
2013). These voltage-gated Ca2þ channels provide a major mecha-
nism for activity-induced Ca2þ entry into neurons and reg-
ulate multiple neuronal cell functions, including excitability,under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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aberrant activity of LTCCs and dysregulation of Ca2þ homeostasis
might be involved in AD pathology (Green et al., 2007; Santos et al.,
2010).
Transgenic mice overexpressing human amyloid precursor
protein (APP) with mutations that predispose for familial AD, pro-
vide potent models for testing speciﬁc alterations associated with
the upregulation of Ab (Crews et al., 2010; Rockenstein et al., 2007).
In recent studies, we demonstrated that intense CaV1.2 a1-subunit-
like immunoreactivity (-LI) is found in reactive astrocytes of 11-
month-old transgenic (tg) mice overexpressing human APP751
with the London (V717I) and Swedish (K670M/N671L) mutations
(Daschil et al., 2013; Willis et al., 2010). However, at present it is
unclear whether the intense staining of CaV1.2 a1-subunit-LI cor-
relates with subunit messenger RNA (mRNA) expression in the
same cells. Up to now, it is unknown how the increased availability
of astroglial CaV1.2 a1-subunits is related to AD pathogenesis.
Furthermore, it is unclear whether this astroglial calcium channel
indeed represents a functional channel. We recently showed
the absence of the b4 subunit in these reactive astrocytes around
plaques (Daschil et al., 2013). Complete immunocytochemical
localization of LTCC subunits is not possible due to the lack of
immunohistochemistry-speciﬁc antibodies.
This study focused on the localization and expression of of b
and a2d subunits using in situ hybridization. For that purpose 11-
month-old wt and tg mice overexpressing human APP with the
London and Swedish mutations (APPSL) were used. Our analysis
focused on the localization of mRNAs in association with Ab
plaques. We compared the expression pattern with that of
preprotachykinin-A (PPT-A) mRNA (the precursor for substance P,
SP), because this peptide has been shown to be localized in reac-
tive astrocytes around plaques. We show that although CaV1.2 a1-
LI is strongly expressed in reactive astrocytes around plaques, its
mRNA is not detectable. It was unexpected to ﬁnd cells expressing
the LTCC subunit and PPT-A mRNAs directly above the plaque core
in the cortex. Using confocal microscopy, we demonstrate that
brain vessels are associated with Ab plaques and express sub-
stance P and an LTCC. We could demonstrate that LTCC blockers
induced angiogenesis of vessels in close proximity to Ab plaques in
cortical organotypic brain slices. This effect was potentiated by the
addition of substance P.2. Methods
2.1. Animals
Transgenic male animals overexpressing human APP751 with
the London (V717I) and Swedish (K670M/N671L) mutations under
the regulatory control of the neuron-speciﬁc murine Thy-1 pro-
moter (mThy-1-hAPP751), heterozygous with respect to the
transgene, on a C57BL/6 background were used (Havas et al., 2011;
Hutter-Paier et al., 2004). The colony was sustained by crossing
APPSL mice and C57BL/6 mice (Harlan Winkelman, Germany). Age-
matched littermates (wt) were used as controls. All mice were
housed according to standard animal care protocols, fed regular
animal diet ad libitum, and maintained in a pathogen-free envi-
ronment in individual ventilated cages at QPS Austria (Grambach,
Austria). The transgenic status of each animal was conﬁrmed by
polymerase chain reaction (PCR) of tail snips using speciﬁc primers
and the appropriate hybridization probe. The age of the animals at
sacriﬁce was 11 months. All experiments were conducted in
accordance with the relevant Austrian Animal Protection and
Welfare Act.For organotypic brain slices wt (C57BL/6N) and tg APP_SDI
(expressing APP and harboring the Swedish K670N/M671L,
Dutch E693Q, and Iowa D694N mutations, C57BL/6-Tg
[Thy1-APPSwDutIowa] BWevn/Mmjax) mice were purchased
from The Jackson Laboratory and housed at the Medical University
of Innsbruck animal facility, providing open access to food and
water under 12 hour-light and 12-hour-dark cycles. The mice have
been generated and extensively characterized by Davis et al. (2004).
2.2. In situ hybridization
In situ hybridization was performed as described (Humpel et al.,
1993; Ullrich et al., 2011). We used the same well-established oli-
gonucleotides as recently published for quantitative real time-PCR
(Daschil et al., 2013; Schlick et al., 2010). Mice were decapitated,
and the brains frozen under a CO2 stream, sectioned (14 mm) with a
cryostat (Leica), and thawed onto slides (ProbeOn slides, Fisher
Biotech, Austria). Oligonucleotides (5 pmol) were labeled at the
30end with [a-35S]dATP using terminal deoxyribonucleotidyl
transferase (Roche, Austria) and puriﬁed on Qiagen columns. The
following oligonucleotides were used for in situ hybridization:
CaV1.2 a1, forward 50-cagcctgctctccacaga-30; CaV1.2 a1/1, reverse
50- gggaatgtggtaggagaatgg-30; CaV1.2 a1/2, reverse 50-caggtagccttt-
gagatcttcttc-30; b1, reverse 50-ctgcctccttccttaaggcttc-30; b2, reverse
50-ctctcttgggtttcagagtcaaa-30; b3, reverse 50-acagtagctga-
cattggtcctcac-30; b4, reverse 50-tgtctcattcgctgactctgtaat-30; a2d-1,
reverse 50-acagtccagtaaaccactgaatga-30; a2d-2, reverse 50-
cttcctgtccagcaggctct-30; a2d-3, reverse 50-atttaatccctgggtactgtctga-
30; a2d-4, reverse 50-caaggaagtctctgcaaccag-30; and PPT-A, reverse
50-cattaatccaaagaactgctgaggcttggg-30. Brain sections were hybrid-
ized overnight at 42 C in a humidiﬁed chamber with 100 mL per
section of the hybridization solution (50% formamide, 4 SSC, 0.02%
polyvinylpyrrolidone, 0.02% Ficoll, 0.02% bovine serum albumin,10%
dextran sulfate, 0.5 mg/mL-sheared salmon sperm DNA, 1% sarcosyl
(N-lauroyl sarcosine), 0.02 M NaPO4 (pH 7.0), and 50 mM dithio-
threitol) containing 1  107 CPM/mL probe. Sections were subse-
quently rinsed, washed 4 times (15 minutes each) in 1 saline
sodium citrate at 54 C, cooled to room temperature, dehydrated
through 70%, 90%, and 99.9% ethanol, and subsequently air-dried.
Sections were dipped in Kodak NTB photo emulsion, exposed for 5
weeks at 20 C, developed, ﬁxed, and counterstained with thio-
ﬂavin S and DAPI (2 hours in the dark), and then mounted with
Vectashield. Sections were stored in the dark at 4 C until analysis.
As a control, selected sections (incubated with radioactively labeled
CaV1.2 oligonucleotides) were incubated with 20 excess of unla-
beled oligonucleotides.
2.3. Immunohistochemistry
Anesthetized mice were perfused transcardially with 20 mL of
phosphate-buffered saline (PBS) and then with 50 mL of 4%
paraformaldehyde (PAF) and 0.05% glutaraldehyde in 0.1 M
phosphate buffer (PB, pH 7.4, without saline). Brains were
dissected and washed in PB and subsequently stored in PB and
0.02% sodium azide at 4 C until use. One half was used for electron
microscopy (data not included and not shown) and the other half
for confocal microscopy. One hemisphere was incubated overnight
at 4 C in PBS containing 20% sucrose, frozen in a CO2 stream, and
stored at 80 C until further processing. Brains were cut into
coronal sections of 40 mm with a cryostat (Leica CM 1950).
Immunohistochemistry was performed as described in detail
(Daschil et al., 2013; Willis et al., 2010). Brain sections were
washed with PBS and incubated in PBS and/or 0.1% Triton (T-PBS)
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tions were blocked in T-PBS, 20% horse serum (GIBCO Invitrogen),
and/or 0.2% BSA (SERVA) for 30 minutes at 20 C while shaking.
Following blocking, brain sections were incubated with primary
antibodies (GFAP, 1:2000, Millipore AB5541; Ab, 1:250, Sigma
A8978; collagen-IV, 1:500, Abcam, ab6586; alpha smooth muscle
actin [aSMA], 1:1000; Novus Biologicals, NB300-978; CaV1.2,
1:2000; Sigma C1603; substance P, 1:100, Bioss, bs-0065R) in T-
PBS and/or 0.2% BSA over 2e3 days at 4 C. The sections were then
washed and incubated with ﬂuorescent Alexa (-488, -546, or -647;
Invitrogen-Life tech, Vienna, Austria) secondary antibodies (anti-
rabbit for collagen-IV, substance P, CaV1.2; anti-mouse for Ab or
anti-goat for aSMA) in T-PBS and/or 0.2% BSA for 1 hour at 20 C
while shaking. Finally, the sections were washed with PBS, some
sections were counterstained with thioﬂavin S or thiazine red
(both Sigma), and then mounted onto glass slides and cover-
slipped with Mowiol 4-88 (Roth, Austria). Confocal microscopy
was performed using an SP5 confocal microscope (Leica Micro-
systems, Wetzlar, Germany) with an HCX PL APO 63 and/or 1.3
NA glycerol objective. Imaging was performed with an argon laser
line for AlexaFluor 488, a DPSS561 nm laser for AlexaFluor 546 or
thiazine red, and a HeNe 633 nm laser for AlexaFluor 647. Emission
of each ﬂuorophore was detected from 493 to 556 nm (AlexaFluor
488), 566 to 628 nm (AlexaFluor 546, thiazine red), and 638 to 750
nm (AlexaFluor 647). Images were acquired using the LAS AF
acquisition software, version 2.1., and further processed with
Huygens Deconvolution and Imaris V6.4 software.2.4. Organotypic cortex brain slices
For cortex vibrosection cultures,12-month-old adult APP_SweDI
mice (developing extensive plaques) were used. All experiments
conformed to Austrian guidelines on the ethical use of animals.
Experimental steps were taken to reduce suffering and the numberFig. 1. Immunohistochemical staining for reactive glial-ﬁbrillary acidic protein (GFAPþ) astr
(B). A plaque was identiﬁed by thioﬂavin S staining under the ﬂuorescence microscope and t
circled. In situ hybridization for PPT-A (C and D) mRNA in an 11-month-old APPSL mouse. T
centered directly above the thioﬂavin S-stained plaques (D). Scale bar in A ¼ 40 mm. Abbreof animals used. Vibrosections were performed as described in
detail (Ullrich et al., 2011). The animals were rapidly sacriﬁced, the
brains dissected, and sagittally cut. The brains were glued onto the
chuck of a water-cooled vibratome Leica VT1000A and triggered
close to a commercial shave racer. Under aseptic conditions,120-mm
vibrosections were cut and collected in sterile medium. The orga-
notypic vibrosections were carefully placed onto a sterile 0.4-mm
pore membrane (Millipore HTTP02500), which was then placed
into a 0.4-mm membrane insert (Millipore PICM03050) within a 6-
well plate. Vibrosections were cultured in 6-well plates (Greiner) at
37 C and 5% CO2with 1.2mL/well of the following culturemedium:
50% MEM and/or HEPES (Gibco), 25% heat-inactivated horse serum
(Gibco, Lifetechnologies, Austria), 25% Hanks’ solution (Gibco), 2
mM NaHCO3 (Merck, Austria), 6.5 mg/mL glucose (Merck, Ger-
many), 2 mM glutamine (Merck, Germany), and pH 7.2. Vibro-
sections were incubated for 4 weeks without or with 10 mM of the
LTCC inhibitors nimodipine, nicardipine, nifedipine, and isradipine
(all Sigma) or with 500 ng/mL substance P (SP acetate salt hydrate,
Sigma S6883) or with both. Slices were then ﬁxed for 3 hours with
4% PAF, then stained for collagen-IV (using Alexa-488), and the
vascular density was counted in a 6  6 grid (Fig. 4) as described by
us in detail (Moser et al., 2003).2.5. Data analysis and statistics
Plaques were identiﬁed by thioﬂavin S staining and photo-
graphed under a ﬂuorescence microscope. Silver grains were
visualized by means of a bright-ﬁeld microscope. Using Openlab
software (4.0.4) both pictures were overlaid to deﬁne the plaque
core (in average 60 mm diameter) and the plaque halo (3 core, in
average 180 mm diameter). The silver grains were counted by
computer-assisted image analysis in the plaque core and in the halo
(see Fig. 1). The total grain number in tg mice was determined
by subtracting the corresponding cortical wt sections. Statisticalocytes (Alexa-488) around thioﬂavin Sþ Ab plaques (A) and deﬁnition of halo and core
he plaque core (average diameter 60 mm) and the halo (3 the diameter of the core) are
he plaques were identiﬁed by thioﬂavin S staining (C). Silver grains of PPT-A mRNA are
viations: Ab, b-amyloid; mRNA, messenger RNA; PPT-A, preprotachykinin-A.
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sequent Fisher least signiﬁcant difference post hoc test. Statistical
results were considered signiﬁcant at p < 0.05.
3. Results
3.1. Detection of plaques in the Alzheimer mouse brain
In 11-month-old tg APP mice, a large number of Ab plaques were
detected. The number and localization were similar to those in pre-
vious studies (Daschil et al., 2013; Willis et al., 2010). No Ab plaques
were found in wt mice. Ab plaques were identiﬁed by Ab immuno-
staining (Fig. 1A), thioﬂavin S (Fig. 1B), thiazine red staining (Fig. 3),
or Congo Red (not shown). The size of the plaques and the distance to
the reactive astroglia allowed us to determine the core and halo
diameter (Fig. 1). This distance is in full agreement with Serrano-
Pozo et al. (2013), including reactive astroglia. Immunohistochem-
istry revealed that the plaques were surrounded by GFAPþ reactive
astrocytes (Fig. 1A). Furthermore, we show that 62%  3% (n ¼ 4) of
all thiazine redþ plaques are associated with collagen-IVþ vessels
(Fig. 4A). These vessels exhibited a thickness of 4.9  0.5 mm.
3.2. Expression of PPT-A mRNA over plaques in the cortex
As a control, the neuropeptide PPT-A was tested for which we
previously showed immunoreactivity in reactive astroglia in the
plaque halo. Surprisingly, PPT-AmRNAwas detected in the core and
to a much lesser extent in the halo (Fig. 1C and D). This was also
veriﬁed by semiquantitative analysis of silver grains in the core and
halo (Table 1). To verify speciﬁcity of the staining, we point to a
focused, strongly centered staining for PPT-A, whereas parts of the
plaque core were negative (Fig. 1C and D).
3.3. Expression of LTCC subunits mRNA in hippocampus and cortex
of wt controls
Several controls were performed to support the speciﬁcity of the
hybridization signal. Because most of the LTCC subunits wereTable 1
Semiquantitative analysis of silver grains for cortical mRNA expression of subunits of
the L-type calcium channel and PPT-A
Probe Wild type (ctx) Sections
analyzed
Transgenic animals (ctx)
Halo Core
Sense (BG) 0.8  0.12 12 1.0  0.07 1.0  0.08
PPT-A 0.9  0.06 23 0.9  0.08 3.1 ± 0.03***
CaV1.2 a1 1.1  0.1 43 1.0  0.09 2.6 ± 0.1*
b1 0.8  0.09 26 1.2  0.08 1.9  0.06
b2 0.9  0.03 26 1.0  0.09 5.8 ± 0.4***
b3 0.7  0.1 14 1.1  0.06 1.8  0.1
b4 1.0  0.1 24 1.4  0.1 5.9 ± 0.3***
a2d-1 0.8  0.08 24 1.1  0.2 5.4 ± 0.3***
a2d-2 0.8  0.01 29 1.1  0.1 1.2  0.1
a2d-3 0.8  0.01 13 0.8  0.07 0.8  0.05
a2d-4 0.9  0.04 15 0.6  0.03 0.7  0.05
The number of analyzed Alzheimer tg and wt brains was n¼ 4. The number of grains
was counted by computer-assisted image analysis directly over the core (diameter
60 mm) or in the halo (180 mm diameter) in 11-month-old mice. Sense oligonucle-
otides deﬁned the background (BG). Semiquantitative analysis showed that 31.1% 
7.7% of all plaques were associated with vessels and expressed the calcium channel
or PPT-A, the precursor for SP. Values are given as mean  SEM grains/100 mm2.
Statistical analysis was performed by one way ANOVA and subsequent Fisher least
signiﬁcant difference post hoc test (*p < 0.05; ***p < 0.001) by comparing against
wild-type cortex (ctx) sections.
Signiﬁcant values are indicated in bold.
Key: ANOVA, analysis of variance; PPT-A, preprotachykinin-A; SEM, standard error
of the mean; SP, substance P.strongly expressed in the hippocampal formation, it was especially
evaluated in age-matched 11-month-old wt mice. Comparison of
probes for different LTCC subunits, mRNA revealed a speciﬁc
expression patternwith regard to distribution and expression levels
in the hippocampal formation for CaV1.2 a1 (Fig. 2D), b4 (Fig. 2G),
and all other LTCC subunits (data not shown), except a2d-4, which
was not expressed. In addition, the a2d-2 subunit mRNA was
markedly expressed in the medial habenula (data not shown).
Sense oligonucleotide probes revealed only background staining in
the hippocampus (Fig. 2A). For CaV1.2 a1, we used 2 different probes
complementary for different regions within its gene, which
revealed an identical expression pattern (data not shown). The
expression of the LTCC subunit mRNAs in the parietal cortex of wt
mice displayed a diffuse pattern (shown for a1 and b4 in Fig. 2E and
H) and was slightly above the sense background (Fig. 2B; Table 1)
and below the tg grain density (Fig. 2F and I; Table 1).
3.4. Expression of LTCC subunits mRNA in plaques in the cortex of tg
mice
Background staining was especially evaluated in association with
Ab plaques and again sense probes displayed only background
staining in tg cortex (Fig. 2C). In contrast to our hypothesis, CaV1.2 a1
mRNA was not expressed in the plaque halo (Fig. 2F). Similarly, b4
mRNAwas not expressed in the plaque halo (Fig. 2I), and none of the
other b or a2d subunits were found in the halo (data not shown). This
was also veriﬁed by semiquantitative analysis of silver grains
(Table 1). Surprisingly, the grain densities for CaV1.2 a1 (Fig. 2F), b2, b4
(Fig. 2I), and a2d-1 were signiﬁcantly enhanced directly above the
plaque core, whereas all other auxiliary subunits did not differ from
wt mice (data not shown). Again, this was also veriﬁed by semi-
quantitative analysis of silver grains (Table 1). When a 20 excess of
unlabeled oligonucleotides were added to CaV1.2 a1 radioactive oli-
gonucleotides, no grains were detected over plaques (data not
shown). Semiquantitative analysis showed that 31.1%  7.7% of
plaque-associated vessels express the calcium channel or substance P.
3.5. Confocal microscopy of vessels around Ab plaques in the cortex
Confocal microscopy conﬁrms that collagen-IVþ brain vessels
are associated with Ab plaques in the AD mouse model (Fig. 3A).
Furthermore, these vessels also contain pericytes expressing aSMA
(Fig. 3B). Immunostaining for the a1 subunit of CaV1.2 shows a
diffuse unclear immunoreactivity, located mainly around the pla-
que in an intermediate zone between the core and the halo (Fig. 3C).
Substance P-like immunoreactive cells are clearly associated with
Ab plaques (Fig. 3D). To perform triple staining with 2 antibodies,
we stained plaques with thiazine red, which was as potent as the Ab
immunohistochemistry (Fig. 3EeI). Triple staining revealed that
aSMAþ pericytes were indeed located in collagen-IVþ vessels
associated with thiazine red plaques (Fig. 3E). Comparison of sec-
tions stained with immunohistochemistry and sections labeled by
in situ hybridization clearly showed that immunoreactive cells
correspond to the silver grains directly in the plaque core (Fig. 3F).
Triple staining for pericytes, SP, and thiazine red plaques revealed
that SP-immunostained cells were located together with pericytes
in vessels associated with the plaque (Fig. 3GeI).
3.6. Angiogenesis in cortical organotypic brain slices
Ab plaques were largely associated with collagen-IVþ brain
vessels (Fig. 4A). In adult slices of the APP_SweDI mice, Ab plaques
were visualized by thiazine red staining after culturing for 4 weeks
(Fig. 4B). These slices exhibited a dense collagen-IVþ vascular
network (Fig. 4C), which was quantiﬁed in a 6  6 grid (Fig. 4D)
Fig. 2. In situ hybridization for CaV1.2 and auxiliary calcium-channel subunits in 11-month-old wt mice in the hippocampal formation (A, D, and G) and cortex (B, E, and H) and in tg
mice in the cortex, where plaques were counterstained with thioﬂavin S (C, F, and I). The sense oligonucleotide revealed only background silver grains in the hippocampus (A) and
cortex (B and C). The CaV1.2 a1 (DeF) and b4 (GeI) antisense oligonucleotides-labeled neurons in the hippocampus (D and G), whereas only the background is seen in the wt cortex
(E and H). Note, enhanced silver grain densities directly over the thioﬂavin S stained plaque core (F and I) for both probes. Scale bar in A ¼ 210 mm (A, D, and G) and 70 mm (B, C, E, F,
H, and I). Abbreviation: tg, transgenic; wt, wild type.
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(Table 2). SP and all tested LTCC blockers induced angiogenesis in
cortical slices (Table 2), which was slightly potentiated when both
substances were applied (Table 2).
4. Discussion
In the present study, we show for the ﬁrst time that mRNAs for
an entire LTCC and PPT-A (the precursor for SP) were expressed
above the Ab plaque core in the cortex of Alzheimer mice. We
further provide evidence that this calcium channel and SP are
expressed on cortical brain vessels, and that both substances induce
angiogenesis of plaque-associated vessels.
4.1. Ab plaques in Alzheimer mice
The use of tg mice to study plaques is well-established, and we
have extensively used these APPSL-overexpressing mice (Daschil
et al., 2013; Willis et al., 2007, 2008, 2010). The plaques consist of
a central core of highly aggregated Ab peptides and a halo
surrounding the plaques, with migrated reactive astrocytes and
microglia. The most robust deﬁcits occur in this halo around the
plaques within a radius of approximately 20 mm, including local
alterations in spine density, neuritic curvature, calcium dysregula-
tion, and oxidative stress (Xie et al., 2013). We recently showed that
these reactive astrocytes express the CaV1.2 a1 subunit of the LTCC
channel (Daschil et al., 2013). We also showed that these reactiveastrocytes express different neuropeptides, such as SP (Willis et al.,
2007). Thus, in the present study this neuropeptide should serve as
a positive control.
4.2. Expression of PPT-A mRNA in Ab plaques localized in the cortex
It was rather surprising to ﬁnd PPT-A mRNA expression directly
over the Ab plaque core. PPT-A mRNA expression was localized in
cells in the plaque core, possibly representing plaque associated
vessels. No PPT-A mRNA expression was found in the halo of the
plaque. Unfortunately, in situ hybridization does not allow co-
localization studies with immunohistochemistry; however, our
immunostainings provide evidence that SP is expressed on brain
vessels associated with plaques. It is well-established that SP plays
an important role in angiogenesis (Albrecht-Schgoer et al., 2012;
Kohara et al., 2010; Pelletier et al., 2002; Seegers et al., 2003;
Wiedermann et al., 1996), and, in fact, there is clear evidence that
SP is expressed in endothelial cells (Milner et al., 2004; Stones et al.,
1995), airway smooth muscle cells (Maghni et al., 2003), and peri-
cytes (Maghni et al., 2003). Indeed, using organotypic brain cultures
of adult AD mice, we show that SP exerts a strong and signiﬁcant
angiogenetic effect on brain vessels associated with plaques.
4.3. Plaques and vessels
There are clear indications that AD is linked to a vascular
pathology (de la Torre, 2002; Humpel, 2011; Iadecola, 2004).
Fig. 3. Confocal microscopy of vessels associated with Ab plaques in the cortex of an AD mouse model. Plaques were stained either by Ab immunohistochemistry (AeD) or with
thiazine red (EeI). Brain vessels were identiﬁed with a collagen-IV staining (A and E) and pericytes using aSMA (B, E, F, G, and I). Both markers clearly labeled brain vessels associated
with Ab plaques (E). The a1 subunit of the CaV1.2-LI was found mainly as a diffuse unclear pattern in an intermediate zone between the core and the halo (C), whereas SP was clearly
found in cells close to the plaque (D). Comparison of sections stained with immunohistochemistry and sections labeled by in situ hybridization clearly shows that immunoreactive
cells correspond to the silver grains directly in the plaque core (F). Triple staining illustrates that SP (H) co-stains with aSMA (G), demonstrating expression of SP in brain vessels
associated with plaques (I). Scale bar in A ¼ 10 mm (AeI). Abbreviations: aSMA, alpha smooth muscle actin; Ab, b-amyloid; AD, Alzheimer’s disease; SP, substance P.
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changes in blood vessels and modiﬁed blood ﬂow (Beckmann
et al., 2003.). It is well known that 95% of dense plaques in
Tg2576 and 85% in PSAPP mice are centered on vessel walls or in
the immediate perivascular region (Kumar-Singh et al., 2005). An
autopsy study of AD patients showed 60%e77% of Ab plaques tobe associated with blood vessels, however, 8%e13% of Ab plaques
are penetrated by vessels, and this vessel density is higher in the
border zone of plaques (Kawai et al., 1990). In human sporadic
AD patients, classic Ab deposits cluster around large diameter
blood vessels rather than capillaries (Armstrong, 2006).
Impressive 3D electron microscopy clearly shows early Ab
Fig. 4. Collagen-IVþ brain vessels are directly associated with thiazine redþ plaques (A, *) of the APP_SweDI Alzheimermouse model. In adult cortical organotypic brain vibrosections of
an APP_SweDI Alzheimer mouse model, a high number of thiazine red plaques (shown in a black-white picture) is visible in the cortex after 4 weeks of incubation (B). These brain slices
contain a dense network of collagen-IVþ (Alexa-488, green) brain vessels. Semiquantitative analysis of brain vessels was performed in a 6  6 grid by counting the crossings of the
vessels (C, D). Scale bar in A ¼ 25 mm, BeD ¼ 85 mm.
Table 2
Angiogenetic effects of LTCC blockers and SP on plaque-associated vessels in cortical
organotypic brain sections of adult Alzheimer mice
Treatment Vessel density p versus minus p-values
Minus 76  1.8 (16) d
SP 102  5.8 (20) ***
ISR 110  1.6 (11) ***
NIM 110  2.2 (18) ***
NIF 111  2.2 (9) ***
NIC 91  2.4 (8) **
SP þ ISR 113  2.9 (11) * versus SP NS versus ISR
SP þ NIM 123  3.8 (12) * versus SP ** versus NIM
Cortical vibrosections (120-mm thick) were cultured from 12-month-old APP_SweDI
mice for 4 weeks without (minus), with 500 ng/mL SP, with 10 mM of the LTCC
blockers isradipine (ISR), nimodipine (NIM), nifedipine (NIF), or nicardipine (NIC) or
with both, SP and LTCC blockers for 4 weeks. Sections were then ﬁxed and immu-
nohistochemically stained for collagen-IV using Alexa-488. The vascular density was
counted in a 6  6 grid at a 10 magniﬁcation. Statistical analysis was performed
by one way ANOVA and Fisher least signiﬁcant difference post hoc test; *p < 0.05;
**p < 0.01; ***p < 0.001.
Key: ANOVA, analysis of variance; LTCC, L-type calcium channel; SP, substance P.
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shaped clumps clinging to brain microvessels in an AD mouse
model (Meyer et al., 2008). Damage to the microvasculature
begins before the onset of parenchymal Ab plaques or vascular
amyloid deposition (Meyer et al., 2008). Our present data are in
line and show that approximately 60% of all Ab plaques are
associated with vessels.
4.4. Expression of LTCCs in the cortex
In our hands, in situ hybridization is a well-established and
potent tool for visualizing mRNA expression at the cellular level
(Humpel et al., 1993). Radioactive probes (35S) are more sensitive
than nonradioactive (e.g., digoxigenin) probes. Although the use of
riboprobes is highly speciﬁc and sensitive, we did not have access to
such probes and therefore used commercial oligonucleotide probes.
All these oligonucleotide probes have been well-characterized and
applied in previous quantitative real time-PCR analyses (Daschil
et al., 2013; Schlick et al., 2010). The present study detected high
expression levels for most of the LTCC subunits, which is in line
with a previous study (Schlick et al., 2010). Our data show that all
probes were selective and speciﬁc for the LTCC subunits and dis-
played a well-known and established pattern for mRNA expression
of CaV1.2 a1 (Ludwig et al., 1997), the b1e4 auxiliary subunits
(Ludwig et al., 1997), and the a2d subunits (Cole et al., 2005) in the
hippocampal formation.
4.5. Expression of LTCCs mRNA above the plaques in the cortex
We did not detect mRNA expression for CaV1.2 a1 around the
plaques in the halo, which is in contrast to ourimmunocytochemical study (Daschil et al., 2013; Willis et al., 2010).
This mismatch between mRNA expression and protein has several
potential explanations. The most likely reason is that the increased
expression of the protein downregulates its own mRNA expression
via negative feedback regulation (Groth et al., 2014). This is also in
line with our recent ﬁndings, where we show (Daschil et al., 2014)
that a chronic 3 week addition of Ab42 to primary astrocytes down-
regulates the mRNA expression of CaV1.2 a1 subunits. In addition, it
seems also possible that enhanced degradation and turnover may
contribute to the down-regulation of the mRNA expression.
N. Daschil et al. / Neurobiology of Aging 36 (2015) 1333e13411340Increased processing and alternative splicings including epigenetic
mechanisms may also occur.4.6. LTCC linked to the vascular system in Ab plaques
It was rather unexpected to ﬁnd silver grains for CaV1.2 a1, and
more pronounced for b2 and/or b4 and a2d-1 subunits, located
directly above the plaque core. As we rigorously controlled for
speciﬁcity, our data indicate that cells located directly on the core of
the plaques indeed express LTCC subunits. Thus, our data show that
these cells located above the plaques express the CaV1.2 a1/b2/b4/
a2d-1 proﬁle. In fact, it is known that the CaV1.2 channel with the
a1/b2/b4/a2d-1 proﬁle is directly associated with the vascular sys-
tem, for example, on pericytes. In the brain, the pericyte is an in-
tegral cellular component of the blood-brain barrier and together
with endothelial cells, astrocytes, and neurons form the neuro-
vascular unit. Pericytes have been proposed to play a role in func-
tional activities of the blood-brain barrier, microcirculation, and
macrophage activity, and it has been shown that calcium enters
central nervous system pericytes via LTCCs (Kamouchi et al., 2004).
The existence of LTCCs in smooth muscle cells of major cerebral
arteries and arterioles is well-established (Abd El-Rahmann et al.,
2013; Alborch et al., 1995; Reimer et al., 2000). Furthermore,
myocytes and pericytes are electrically coupled, transmitting cal-
cium signals between arteriolar and venular networks dependent
on gap junctions and calcium entry via LTCCs (Borysova et al., 2013).
And, ﬁnally, also pericytes of the descending vasa recta express
voltage-gated divalent currents that are carried by LTCCs (Zhang
et al., 2010). It needs to be proven in further experiments that
indeed pericytes express an LTCC and SP. Anyhow, our in vitro data
clearly show that LTCCs directly induce angiogenesis of vessels
associated with plaques in an AD mouse model and SP slightly
potentiated this effect. The intracellular mechanisms are unknown;
however, it has been shown that SP activated calcium-dependent
nitric oxide in endothelial cells of the rabbit cornea (Ziche et al.,
1994), which was necessary for neovascularization, a process,
which could also occur in the brain.4.7. Study limitations
The present study has some methodological limitations. (1)
Combination of the radioactive in situ hybridization method and
immunocytochemistry on the same section did not yield reliable
results. Therefore, we cannot provide direct evidence for localiza-
tion of LTCC and SP mRNA and/or protein on the same section. (2)
Speciﬁc antibodies for various LTCC subunits are not available,
which is a major drawback for the cellular and subcellular locali-
zation of these proteins. A detailed subunit composition of LTCC
subunits could not be performed because of the lack of speciﬁc
antibodies except CaV1.2 and b4. (3) The cross-sectional design of
the study prevented us from clarifying whether the expression
pattern is time dependent and whether it is related to the Ab load.
However, the present study is in line with a previous study using
quantitative real time PCR. It also did not reveal longitudinal
changes in the expression pattern of LTCC subunits. (4) We cannot
provide any direct evidence that LTCCs are directly expressed on
pericytes. (5) As we show angiogenesis of collagen-IVþ vessels, we
cannot exclude, although very unlikely, that LTCC blockers or SP just
upregulated collagen-IV expression in the brain vessels, rather than
inducing formation of new tubes.
In conclusion, our data show that brain vessels are closely
associated with Ab plaques in the cortex of an AD mouse model.
These cells express an LTCC and SP, suggesting a potent role in
angiogenesis and vessel plasticity around Ab plaques in AD.Disclosure statement
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